The goals of this predoctoral Training Program in the Pharmacological Sciences at the University of Virginia are to provide rigorous training in scientific inquiry while imbuing each trainee with a professional, scholarly mindset. Our training regimen provides a broad education in modern pharmacology that includes fundamental aspects of physiology, pharmacodynamics, pharmacokinetic and bioinformatics. The program emphasizes critical thinking and technical skills as well as oral and written presentations of experimental findings and ideas. A training grant Steering Committee administers the training program and oversees student progress through performance in course work, qualifying examinations, presentations in the Pharmacology journal club and written reports from semi-annual committee meetings. There are currently 20 trainees; we admit 3-4 new trainees each year. Training grant eligible students (24-36 annually) enter graduate school through an umbrella program. During the first year, students enroll in a core knowledge course and perform three research rotations. They choose their dissertation mentor and PhD program mid-way in their second semester. On joining the laboratories of the 43 Pharmacological Sciences Training Grant preceptors, they can be nominated for appointment to the training grant for their second and third years in graduate school. In addition to supporting Pharmacology PhD students, this training grant has supported students in the Biochemistry, Biomedical Engineering, Chemistry, Pathology, Microbiology, Neuroscience and Physiology PhD programs. Training program-specific activities include courses in human physiology, general pharmacology, analysis of drug targets, bioinformatics, and the responsible conduct of research as well as participation in the weekly Pharmacology journal club. Non-Pharmacology PhD students are required to matriculate in one pharmacology course, bioinformatics and the Pharmacology journal club while appointed to the training grant and are strongly encouraged to continue this participation for the duration of graduate school. All faculty preceptors are tenure-track faculty with robust research programs. A plurality of preceptors have primary appointments in Pharmacology; the other preceptors represent ten additional academic units; five preceptors are active clinicians. Twenty-two trainees have been awarded the PhD in past five years and 15 more remain in training. Nine of these trainees were awarded individual predoctoral fellowships and our trainees have published, on average, three original research papers (one as first author) while in training. The time-to- degree of our trainees is 5.2 years. With this application for renewal of the training grant, we request continued support for five years (-44 to -48) for seven trainees yearly.

Public Health Relevance

The Pharmacological Sciences Training Grant at the University of Virginia supports training of graduate students interested in Pharmacology ? a discipline that focuses on the discovery and understanding of medicines. Our program brings together 43 faculty members drawn from eleven departments in the School of Medicine, School of Engineering and Applied Sciences and the College of Arts & Sciences to provide training in Pharmacology to trainees enrolled in Pharmacology, Biochemistry, Physiology, Biomedical Engineering, Neuroscience, Microbiology and Chemistry PhD programs. The overall mission of the Pharmacology training program is to train a diverse set of students to become outstanding scientists and thereby contribute to our nation?s scientific workforce.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM007055-46
Application #
9974510
Study Section
NIGMS Initial Review Group (TWD)
Program Officer
Koduri, Sailaja
Project Start
1985-07-01
Project End
2023-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
46
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Virginia
Department
Pharmacology
Type
Schools of Medicine
DUNS #
065391526
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Kerur, Nagaraj; Fukuda, Shinichi; Banerjee, Daipayan et al. (2018) cGAS drives noncanonical-inflammasome activation in age-related macular degeneration. Nat Med 24:50-61
Olmez, Inan; Love, Shawn; Xiao, Aizhen et al. (2018) Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha. Neuro Oncol 20:192-202
Campbell, Sean T; Franks, Caroline E; Borne, Adam L et al. (2018) Chemoproteomic Discovery of a Ritanserin-Targeted Kinase Network Mediating Apoptotic Cell Death of Lung Tumor Cells. Mol Pharmacol 94:1246-1255
Meher, Akshaya K; Spinosa, Michael; Davis, John P et al. (2018) Novel Role of IL (Interleukin)-1? in Neutrophil Extracellular Trap Formation and Abdominal Aortic Aneurysms. Arterioscler Thromb Vasc Biol 38:843-853
Shin, Myungsun; Franks, Caroline E; Hsu, Ku-Lung (2018) Isoform-selective activity-based profiling of ERK signaling. Chem Sci 9:2419-2431
McCloud, Rebecca L; Franks, Caroline E; Campbell, Sean T et al. (2018) Deconstructing Lipid Kinase Inhibitors by Chemical Proteomics. Biochemistry 57:231-236
Serbulea, Vlad; Upchurch, Clint M; Ahern, Katelyn W et al. (2018) Macrophages sensing oxidized DAMPs reprogram their metabolism to support redox homeostasis and inflammation through a TLR2-Syk-ceramide dependent mechanism. Mol Metab 7:23-34
Narahari, Adishesh K; Mehaffey, J Hunter; Hawkins, Robert B et al. (2018) Surgeon Scientists Are Disproportionately Affected by Declining NIH Funding Rates. J Am Coll Surg 226:474-481
Schappe, Michael S; Szteyn, Kalina; Stremska, Marta E et al. (2018) Chanzyme TRPM7 Mediates the Ca2+ Influx Essential for Lipopolysaccharide-Induced Toll-Like Receptor 4 Endocytosis and Macrophage Activation. Immunity 48:59-74.e5
Schweitzer, George G; Collier, Sara L; Chen, Zhouji et al. (2018) Loss of lipin 1-mediated phosphatidic acid phosphohydrolase activity in muscle leads to skeletal myopathy in mice. FASEB J :fj201800361R

Showing the most recent 10 out of 93 publications